Study of simian foamy virus spread to people in Cameroon
Part of Infections clinical trials.
This study looks at how a virus found in animals (simian foamy virus) may spread to humans. It aims to learn who might be exposed and how the infection can be detected in a rural community, which could help future prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in a rural area in Cameroon
- You are older than 5 years
- You can receive the study information and understand it
- You (and your children, if applicable) must give written consent to join
- If you or your children do not agree to consent, you cannot join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at rare types of HIV (not the common group M) using stored blood samples from people in Cameroon. It may help researchers understand these rare virus types better, but participation is limited to specific locations and time periods.
This study follows people with mpox and their close contacts in Guinea to learn how the virus spreads and to measure how well the mpox vaccine works. You would be involved for up to two months and help improve prevention and care.
This study looks at how infections spread in villages in Cambodia. If you live in a participating village, you might help us understand and prevent disease outbreaks.
This trial checks how well antibodies from COVID-19 or monkeypox vaccines or treatments work in adults. It helps researchers understand your protection level.
This study aims to understand how people's immune systems respond to viruses that spread from animals to humans (zoonotic viruses). If you have had recent contact with potentially infected animals in Cambodia, your participation can help researchers find ways to detect and prevent future outbreaks.
This study looks at the medical and lab changes in people with suspected or likely monkeypox, and in adults who may be eligible for a monkeypox vaccine. Your participation helps researchers understand how infection and vaccination affect the body and how to improve care.
Hear when a new Simian Foamy Virus Infection (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.